Venrock Adviser, LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Venrock Adviser, LLC disclosed 33 US equity positions worth $2.7bn in its Q1 2026 13F filing. The largest position was APGE at 26.7% of the reported book, followed by ERAS and ORKA.
What did Venrock Adviser, LLC own in Q1 2026? Top 33 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | APGE APOGEE THERAPEUTICS INC | Healthcare | 26.7% | $714.9m | 8,493,321 | – | |
| 2 | ERAS ERASCA INC | Healthcare | 9.9% | $265.1m | 16,382,812 | – | |
| 3 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 7.6% | $203.5m | 4,148,428 | – | |
| 4 | SYRE SPYRE THERAPEUTICS INC | Healthcare | 6.9% | $185.9m | 3,685,448 | – | |
| 5 | 4XC1 KALVISTA PHARMACEUTICALS INC | 4.9% | $130.3m | 6,474,485 | – | ||
| 6 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 3.7% | $99.0m | 1,180,000 | – | |
| 7 | DMRA DAMORA THERAPEUTICS INC | Healthcare | 3.5% | $93.3m | 3,603,595 | – | |
| 8 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 3.3% | $87.6m | 10,346,926 | – | |
| 9 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.9% | $77.0m | 2,000,000 | – | |
| 10 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 2.8% | $75.9m | 3,882,709 | – | |
| 11 | SVRA SAVARA INC | Healthcare | 2.8% | $75.0m | 13,740,375 | – | |
| 12 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 2.5% | $67.7m | 1,726,331 | – | |
| 13 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 2.0% | $54.7m | 4,319,765 | – | |
| 14 | VOR VOR BIOPHARMA INC | Healthcare | 2.0% | $54.3m | 3,041,719 | – | |
| 15 | MAZE MAZE THERAPEUTICS INC | Healthcare | 1.8% | $47.8m | 1,602,034 | – | |
| 16 | CTMX CYTOMX THERAPEUTICS INC | Healthcare | 1.8% | $46.9m | 9,982,124 | – | |
| 17 | JBIO JADE BIOSCIENCES INC | Healthcare | 1.7% | $45.2m | 3,220,364 | – | |
| 18 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.5% | $39.4m | 2,173,913 | – | |
| 19 | CBIO CRESCENT BIOPHARMA INC. | 1.5% | $39.2m | 2,133,576 | – | ||
| 20 | ZURA ZURA BIO LTD | Healthcare | 1.4% | $38.3m | 6,434,990 | – | |
| 21 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 1.3% | $33.7m | 4,843,380 | – | |
| 22 | ENGENE HOLDINGS INC | 1.2% | $32.5m | 4,771,414 | – | ||
| 23 | TENX TENAX THERAPEUTICS INC | 1.0% | $26.8m | 1,675,262 | – | ||
| 24 | ANL ADLAI NORTYE LTD | 0.8% | $22.2m | 3,212,731 | – | ||
| 25 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 0.7% | $19.7m | 8,695,652 | – | |
| 26 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 0.7% | $19.6m | 1,379,965 | – | |
| 27 | HELP CYBIN INC | 0.7% | $18.5m | 3,851,654 | – | ||
| 28 | SRZN SURROZEN INC | 0.7% | $18.4m | 632,931 | – | ||
| 29 | SEPN SEPTERNA INC | Healthcare | 0.5% | $12.2m | 506,056 | – | |
| 30 | KRRO KORRO BIO INC | Healthcare | 0.4% | $11.4m | 1,009,500 | – | |
| 31 | ANRO ALTO NEUROSCIENCE INC | Healthcare | 0.4% | $11.2m | 500,000 | – | |
| 32 | ARTV ARTIVA BIOTHERAPEUTICS INC | 0.4% | $10.4m | 1,609,569 | – | ||
| 33 | XFOR X4 PHARMACEUTICALS INC | 0.1% | $1.4m | 330,525 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.